Primo Chemicals（506852）株式概要プリモ・ケミカルズ社はインドで化学品の製造・販売を行っている。 詳細506852 ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績4/6財務の健全性3/6配当金0/6報酬過去1年間で収益は331.8%増加しました リスク分析過去5年間で収益は年間26%減少しました。 意味のある時価総額がありません ( ₹6B )Indian市場と比較した過去 3 か月間の株価の変動すべてのリスクチェックを見る506852 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW477,249 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA477,249 investors already sharing narrativesYour Fair Value₹Current Price₹25.1835.5% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-253m8b2016201920222025202620282031Revenue ₹8.2bEarnings ₹223.8mAdvancedSet Fair ValueView all narrativesPrimo Chemicals Limited 競合他社Beezaasan ExplotechSymbol: BSE:544369Market cap: ₹5.0bTranspek IndustrySymbol: BSE:506687Market cap: ₹7.3bPetro Carbon and ChemicalsSymbol: NSEI:PCCLMarket cap: ₹7.0bAgarwal IndustrialSymbol: BSE:531921Market cap: ₹7.5b価格と性能株価の高値、安値、推移の概要Primo Chemicals過去の株価現在の株価₹25.1852週高値₹28.9352週安値₹16.21ベータ-0.361ヶ月の変化4.96%3ヶ月変化8.91%1年変化-8.70%3年間の変化-59.72%5年間の変化7.75%IPOからの変化187.77%最新ニュースValuation Update With 7 Day Price Move • Jun 08Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹26.36, the stock trades at a trailing P/E ratio of 41.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 58% over the past three years.New Risk • Jun 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 26% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.6% average weekly change). Market cap is less than US$100m (₹6.39b market cap, or US$67.2m).Reported Earnings • May 06Full year 2026 earnings released: EPS: ₹0.63 (vs ₹0.15 in FY 2025)Full year 2026 results: EPS: ₹0.63 (up from ₹0.15 in FY 2025). Revenue: ₹5.81b (up 4.7% from FY 2025). Net income: ₹153.7m (up 332% from FY 2025). Profit margin: 2.6% (up from 0.6% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 42 percentage points per year, which is a significant difference in performance.お知らせ • Apr 29Primo Chemicals Limited to Report Q4, 2026 Results on May 05, 2026Primo Chemicals Limited announced that they will report Q4, 2026 results on May 05, 2026Valuation Update With 7 Day Price Move • Apr 02Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₹21.54, the stock trades at a trailing P/E ratio of 58.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 72% over the past three years.New Risk • Feb 14New major risk - Revenue and earnings growthEarnings have declined by 20% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₹5.35b market cap, or US$59.0m).最新情報をもっと見るRecent updatesValuation Update With 7 Day Price Move • Jun 08Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹26.36, the stock trades at a trailing P/E ratio of 41.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 58% over the past three years.New Risk • Jun 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 26% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.6% average weekly change). Market cap is less than US$100m (₹6.39b market cap, or US$67.2m).Reported Earnings • May 06Full year 2026 earnings released: EPS: ₹0.63 (vs ₹0.15 in FY 2025)Full year 2026 results: EPS: ₹0.63 (up from ₹0.15 in FY 2025). Revenue: ₹5.81b (up 4.7% from FY 2025). Net income: ₹153.7m (up 332% from FY 2025). Profit margin: 2.6% (up from 0.6% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 42 percentage points per year, which is a significant difference in performance.お知らせ • Apr 29Primo Chemicals Limited to Report Q4, 2026 Results on May 05, 2026Primo Chemicals Limited announced that they will report Q4, 2026 results on May 05, 2026Valuation Update With 7 Day Price Move • Apr 02Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₹21.54, the stock trades at a trailing P/E ratio of 58.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 72% over the past three years.New Risk • Feb 14New major risk - Revenue and earnings growthEarnings have declined by 20% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₹5.35b market cap, or US$59.0m).Reported Earnings • Feb 14Third quarter 2026 earnings released: EPS: ₹0.04 (vs ₹0.09 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.04 (down from ₹0.09 in 3Q 2025). Revenue: ₹1.45b (flat on 3Q 2025). Net income: ₹10.5m (down 54% from 3Q 2025). Profit margin: 0.7% (down from 1.6% in 3Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance.お知らせ • Feb 02Primo Chemicals Limited to Report Q3, 2026 Results on Feb 12, 2026Primo Chemicals Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 12, 2026Reported Earnings • Nov 16Second quarter 2026 earnings released: EPS: ₹0.17 (vs ₹0.53 in 2Q 2025)Second quarter 2026 results: EPS: ₹0.17 (down from ₹0.53 in 2Q 2025). Revenue: ₹1.39b (up 3.6% from 2Q 2025). Net income: ₹41.6m (down 68% from 2Q 2025). Profit margin: 3.0% (down from 9.6% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance.お知らせ • Nov 03Primo Chemicals Limited to Report Q2, 2026 Results on Nov 14, 2025Primo Chemicals Limited announced that they will report Q2, 2026 results at 12:15 PM, Indian Standard Time on Nov 14, 2025お知らせ • Aug 18Primo Chemicals Limited, Annual General Meeting, Sep 30, 2025Primo Chemicals Limited, Annual General Meeting, Sep 30, 2025, at 14:00 Indian Standard Time.Reported Earnings • Aug 16First quarter 2026 earnings released: EPS: ₹0.17 (vs ₹0.46 loss in 1Q 2025)First quarter 2026 results: EPS: ₹0.17 (up from ₹0.46 loss in 1Q 2025). Revenue: ₹1.42b (up 16% from 1Q 2025). Net income: ₹40.8m (up ₹153.3m from 1Q 2025). Profit margin: 2.9% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 65 percentage points per year, which is a significant difference in performance.お知らせ • Aug 04Primo Chemicals Limited to Report Q1, 2026 Results on Aug 14, 2025Primo Chemicals Limited announced that they will report Q1, 2026 results on Aug 14, 2025Reported Earnings • Jun 04Full year 2025 earnings released: EPS: ₹0.15 (vs ₹1.05 loss in FY 2024)Full year 2025 results: EPS: ₹0.15 (up from ₹1.05 loss in FY 2024). Revenue: ₹5.76b (up 45% from FY 2024). Net income: ₹35.6m (up ₹288.9m from FY 2024). Profit margin: 0.6% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 53 percentage points per year, which is a significant difference in performance.お知らせ • May 19Primo Chemicals Limited to Report Q4, 2025 Results on May 30, 2025Primo Chemicals Limited announced that they will report Q4, 2025 results on May 30, 2025New Risk • Apr 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (0.7x net interest cover). Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₹7.00b market cap, or US$81.9m).Valuation Update With 7 Day Price Move • Apr 03Investor sentiment improves as stock rises 36%After last week's 36% share price gain to ₹28.87, the stock trades at a trailing P/E ratio of 63.2x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 67% over the past three years.Reported Earnings • Feb 18Third quarter 2025 earnings released: EPS: ₹0.09 (vs ₹0.63 loss in 3Q 2024)Third quarter 2025 results: EPS: ₹0.09 (up from ₹0.63 loss in 3Q 2024). Revenue: ₹1.49b (up 63% from 3Q 2024). Net income: ₹22.9m (up ₹174.8m from 3Q 2024). Profit margin: 1.5% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 39 percentage points per year, which is a significant difference in performance.お知らせ • Feb 01Primo Chemicals Limited to Report Q3, 2025 Results on Feb 14, 2025Primo Chemicals Limited announced that they will report Q3, 2025 results on Feb 14, 2025New Risk • Jan 13New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.61b (US$99.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (0.05x net interest cover). Minor Risk Market cap is less than US$100m (₹8.61b market cap, or US$99.3m).Recent Insider Transactions • Nov 23Insider recently sold ₹948k worth of stockOn the 19th of November, - Neelam sold around 25k shares on-market at roughly ₹38.55 per share. This transaction amounted to 9.1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹1.3m more than they bought in the last 12 months.お知らせ • Nov 02Primo Chemicals Limited to Report Q2, 2025 Results on Nov 12, 2024Primo Chemicals Limited announced that they will report Q2, 2025 results on Nov 12, 2024Reported Earnings • Aug 13First quarter 2025 earnings released: ₹0.46 loss per share (vs ₹0.18 loss in 1Q 2024)First quarter 2025 results: ₹0.46 loss per share (further deteriorated from ₹0.18 loss in 1Q 2024). Revenue: ₹1.28b (up 16% from 1Q 2024). Net loss: ₹112.5m (loss widened 162% from 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.お知らせ • Aug 12Primo Chemicals Limited, Annual General Meeting, Sep 27, 2024Primo Chemicals Limited, Annual General Meeting, Sep 27, 2024, at 12:30 Indian Standard Time.お知らせ • Aug 01Primo Chemicals Limited to Report Q1, 2025 Results on Aug 12, 2024Primo Chemicals Limited announced that they will report Q1, 2025 results on Aug 12, 2024Reported Earnings • Jun 04Full year 2024 earnings released: ₹1.05 loss per share (vs ₹5.67 profit in FY 2023)Full year 2024 results: ₹1.05 loss per share (down from ₹5.67 profit in FY 2023). Revenue: ₹4.16b (down 41% from FY 2023). Net loss: ₹253.3m (down 118% from profit in FY 2023). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jun 01Primo Chemicals Limited Announces Chief Financial Officer Changes, Effective from July 1, 2024Primo Chemicals Limited at the board meeting held on May 30, 2024, approved the appointment of CA Sunil Parsad as Chief Financial Officer (KMP) of the Company in place of Shri Arun Kumar Kaushal with effect from July 1, 2024. CA Sunil Parsad is B.com, M.com and a qualified Chartered Accountant. He is having a vast experience of around 20+ years in Fund Raising, Finalization of Balance Sheets, Accounts & Finance Control Functions, Arrangement & Management of working capital & Project Finance, Income Tax, TDS, GST, Companies Act, SAP Implementation, managing Statutory & Internal Audit, FEMA/RBI Compliances for export /import & ODI, etc. He has also gained certifications in IND AS Professional from Ernst & Young Associates LLP and Fraud Detection and Forensic Examinations from West Virginia University.お知らせ • May 16Primo Chemicals Limited to Report Q4, 2024 Results on May 30, 2024Primo Chemicals Limited announced that they will report Q4, 2024 results on May 30, 2024New Risk • May 06New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company.New Risk • Apr 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.New Risk • Mar 28New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.26b (US$99.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company.Reported Earnings • Feb 11Third quarter 2024 earnings released: ₹0.63 loss per share (vs ₹1.24 profit in 3Q 2023)Third quarter 2024 results: ₹0.63 loss per share (down from ₹1.24 profit in 3Q 2023). Revenue: ₹951.3m (down 49% from 3Q 2023). Net loss: ₹151.9m (down 151% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 56% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Nov 05Second quarter 2024 earnings released: ₹0.53 loss per share (vs ₹1.72 profit in 2Q 2023)Second quarter 2024 results: ₹0.53 loss per share (down from ₹1.72 profit in 2Q 2023). Revenue: ₹932.0m (down 50% from 2Q 2023). Net loss: ₹129.4m (down 131% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has increased by 81% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Oct 28Primo Chemicals Limited to Report Q2, 2024 Results on Nov 04, 2023Primo Chemicals Limited announced that they will report Q2, 2024 results on Nov 04, 2023Reported Earnings • Aug 17First quarter 2024 earnings released: ₹0.18 loss per share (vs ₹1.98 profit in 1Q 2023)First quarter 2024 results: ₹0.18 loss per share (down from ₹1.98 profit in 1Q 2023). Revenue: ₹1.10b (down 41% from 1Q 2023). Net loss: ₹42.9m (down 109% from profit in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 90% per year but the company’s share price has only increased by 84% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 15Primo Chemicals Limited, Annual General Meeting, Sep 29, 2023Primo Chemicals Limited, Annual General Meeting, Sep 29, 2023, at 12:30 Indian Standard Time.お知らせ • Aug 04Primo Chemicals Limited to Report Q1, 2024 Results on Aug 14, 2023Primo Chemicals Limited announced that they will report Q1, 2024 results on Aug 14, 2023Reported Earnings • May 30Full year 2023 earnings released: EPS: ₹5.67 (vs ₹2.50 in FY 2022)Full year 2023 results: EPS: ₹5.67 (up from ₹2.50 in FY 2022). Revenue: ₹7.34b (up 62% from FY 2022). Net income: ₹1.34b (up 136% from FY 2022). Profit margin: 18% (up from 13% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 106% per year but the company’s share price has increased by 112% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Mar 31Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹80.93, the stock trades at a trailing P/E ratio of 12.1x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 1,295% over the past three years.Valuation Update With 7 Day Price Move • Feb 17Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹78.70, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 1,194% over the past three years.Reported Earnings • Feb 12Third quarter 2023 earnings released: EPS: ₹1.24 (vs ₹1.77 in 3Q 2022)Third quarter 2023 results: EPS: ₹1.24 (down from ₹1.77 in 3Q 2022). Revenue: ₹1.92b (up 47% from 3Q 2022). Net income: ₹300.3m (down 30% from 3Q 2022). Profit margin: 16% (down from 33% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has increased by 119% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Feb 03Primo Chemicals Limited to Report Q3, 2023 Results on Feb 10, 2023Primo Chemicals Limited announced that they will report Q3, 2023 results on Feb 10, 2023お知らせ • Jan 14Primo Chemicals Limited Announces Commissioning of Stable Bleaching Powder ((SBP) Plant At Naya Nangal, PunjabPrimo Chemicals Limited informed that the Company is commissioning Stable Bleaching Powder (SBP) Plant at Naya Nangal, Punjab, having capacity of 33000 MT Per Annum. Name of the Product: Stable Bleaching Powder. Date of launch: January 13, 2023. Category of the Product: Speciality Chemicals.Board Change • Nov 16High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. No highly experienced directors. MD, Director of Marketing & Executive Director Naveen Chopra is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Oct 30Second quarter 2023 earnings released: EPS: ₹1.72 (vs ₹1.57 loss in 2Q 2022)Second quarter 2023 results: EPS: ₹1.72 (up from ₹1.57 loss in 2Q 2022). Revenue: ₹1.95b (up 124% from 2Q 2022). Net income: ₹417.7m (up ₹790.5m from 2Q 2022). Profit margin: 22% (up from net loss in 2Q 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has increased by 113% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Oct 20Punjab Alkalies & Chemicals Limited to Report Q2, 2023 Results on Oct 28, 2022Punjab Alkalies & Chemicals Limited announced that they will report Q2, 2023 results on Oct 28, 2022お知らせ • Aug 12Punjab Alkalies & Chemicals Limited, Annual General Meeting, Sep 15, 2022Punjab Alkalies & Chemicals Limited, Annual General Meeting, Sep 15, 2022, at 12:30 Indian Standard Time.Reported Earnings • Aug 02First quarter 2023 earnings released: EPS: ₹1.98 (vs ₹0.48 in 1Q 2022)First quarter 2023 results: EPS: ₹1.98 (up from ₹0.48 in 1Q 2022). Revenue: ₹1.91b (up 154% from 1Q 2022). Net income: ₹480.0m (up 439% from 1Q 2022). Profit margin: 25% (up from 12% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 94% per year, which means it is well ahead of earnings.お知らせ • Jul 26Punjab Alkalies & Chemicals Limited to Report Q1, 2023 Results on Aug 01, 2022Punjab Alkalies & Chemicals Limited announced that they will report Q1, 2023 results on Aug 01, 2022Valuation Update With 7 Day Price Move • Jun 23Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₹62.65, the stock trades at a trailing P/E ratio of 26.8x. Average trailing P/E is 16x in the Chemicals industry in India. Total returns to shareholders of 336% over the past three years.Reported Earnings • May 20Full year 2022 earnings released: EPS: ₹13.07 (vs ₹0.59 in FY 2021)Full year 2022 results: EPS: ₹13.07 (up from ₹0.59 in FY 2021). Revenue: ₹4.69b (up 107% from FY 2021). Net income: ₹567.2m (up ₹484.8m from FY 2021). Profit margin: 12% (up from 3.6% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has increased by 75% per year, which means it is tracking significantly ahead of earnings growth.Board Change • Apr 27High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. MD, Director of Marketing & Executive Director Naveen Chopra is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹1.77 (up from ₹0.26 in 3Q 2021). Revenue: ₹1.31b (up 125% from 3Q 2021). Net income: ₹429.5m (up ₹393.7m from 3Q 2021). Profit margin: 33% (up from 6.1% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 178 percentage points per year, which is a significant difference in performance.お知らせ • Feb 04Punjab Alkalies & Chemicals Limited to Report Q3, 2022 Results on Feb 11, 2022Punjab Alkalies & Chemicals Limited announced that they will report Q3, 2022 results on Feb 11, 2022Recent Insider Transactions • Jan 07Independent Non-Executive Director recently bought ₹146k worth of stockOn the 31st of December, Kuldip Suhag bought around 500 shares on-market at roughly ₹292 per share. In the last 3 months, there was an even bigger purchase from another insider worth ₹1.7m. Insiders have collectively bought ₹6.8m more in shares than they have sold in the last 12 months.Recent Insider Transactions • Nov 23Insider recently bought ₹1.0m worth of stockOn the 16th of November, Divya Suhag bought around 6k shares on-market at roughly ₹170 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought ₹2.0m more in shares than they have sold in the last 12 months.Reported Earnings • Nov 13Second quarter 2022 earnings released: ₹7.87 loss per share (vs ₹1.28 profit in 2Q 2021)The company reported a poor second quarter result with weaker earnings, revenues and control over costs. Second quarter 2022 results: Revenue: ₹8.94m (down 98% from 2Q 2021). Net loss: ₹3.73m (down 111% from profit in 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 98 percentage points per year, which is a significant difference in performance.Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹133, the stock trades at a trailing P/E ratio of 31.4x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 89% over the past three years.Executive Departure • Sep 06Additional Independent Director Sanjiv Agarwal has left the companyOn the 27th of August, Sanjiv Agarwal's tenure as Additional Independent Director ended after less than a year in the role. We don't have any record of a personal shareholding under Sanjiv's name. A total of 5 executives have left over the last 12 months.Executive Departure • Aug 25Additional Independent Director Girish Bhagat has left the companyOn the 18th of August, Girish Bhagat's tenure as Additional Independent Director ended after less than a year in the role. We don't have any record of a personal shareholding under Girish's name. A total of 4 executives have left over the last 12 months.Reported Earnings • Aug 15First quarter 2022 earnings released: EPS ₹2.41 (vs ₹1.23 loss in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹780.4m (up 114% from 1Q 2021). Net income: ₹89.0m (up ₹122.3m from 1Q 2021). Profit margin: 11% (up from net loss in 1Q 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Jul 26Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹111, the stock trades at a trailing P/E ratio of 37.3x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 93% over the past three years.お知らせ • May 24Punjab Alkalies & Chemicals Limited announced that it has received INR 324 million in funding from Plutus Wealth Management LLP and other investorsOn May 22, 2021, Punjab Alkalies & Chemicals Limited (BSE:506852) closed the transaction. The transaction has been approved by the board of directors of the company.Reported Earnings • May 24Full year 2021 earnings released: EPS ₹2.97 (vs ₹3.24 in FY 2020)The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2021 results: Revenue: ₹2.81b (down 3.1% from FY 2020). Net income: ₹82.4m (down 6.5% from FY 2020). Profit margin: 2.9% (in line with FY 2020). Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.お知らせ • Mar 18Punjab Alkalies & Chemicals Limited announced that it expects to receive INR 324 million in funding from Plutus Wealth Management LLP, and other investorsPunjab Alkalies & Chemicals Limited (BSE:506852) announced a private placement of 5,400,000 shares at issue price of INR 60 per share for gross proceeds of INR 324,000,000 on March 16, 2021. The transaction will include participation from Plutus Wealth Management LLP for 2,500,000 shares, Hemlata Kamal Poddar for 400,000 shares, Arun Kumar Poddar for 400,000 shares, Anita Kedia, Anup Gupta, Nand Kishore Agarwal, Rajesh Gadodia, Rajesh Kumar Agarwal, Ratiraj Tibrewal, Shyamsunder Bharubaxn Mandawewala, Poonam Sunil Bagaria, Amar Jeet Singh Randhawa, Aman Preet Singh Sohi for 200,000 shares each, and Sameer Agarwal for 100,000 shares. The transaction has been approved by the board of directors of the company. The company will raise money through preferential allotment.Is New 90 Day High Low • Mar 09New 90-day high: ₹61.70The company is up 26% from its price of ₹48.90 on 09 December 2020. The Indian market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.Reported Earnings • Feb 13Third quarter 2021 earnings released: EPS ₹1.32 (vs ₹0.02 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹653.0m (up 10.0% from 3Q 2020). Net income: ₹35.8m (up ₹36.3m from 3Q 2020). Profit margin: 5.5% (up from net loss in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 34% per year, which means it is well ahead of earnings.お知らせ • Feb 05Punjab Alkalies & Chemicals Limited to Report Q3, 2021 Results on Feb 12, 2021Punjab Alkalies & Chemicals Limited announced that they will report Q3, 2021 results on Feb 12, 2021お知らせ • Feb 04Punjab Alkalies & Chemicals Limited Announces Board AppointmentsThe Board of Directors of Punjab Alkalies & Chemicals Limited in its meeting held on February 03, 2021 approved appointment of Shri Girish Bhagat as Additional Director in an Independent capacity with effect from February 03, 2021 and appointment of Dr. Sanjiv Agarwal as Additional Director in an Independent capacity with effect from February 3, 2021 till the date of the next Annual General Meeting.Is New 90 Day High Low • Jan 20New 90-day high: ₹55.35The company is up 13% from its price of ₹49.00 on 22 October 2020. The Indian market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.お知らせ • Dec 02Punjab Alkalies & Chemicals Limited Approves Directorate AppointmentPunjab Alkalies & Chemicals Limited at its EGM held on December 1, 2020 approved the appointment of Shri Ashok Goyal as an Independent Director, not liable to retire by rotation, for a term of five consecutive years with effect from 1 December 2020, appointment of Shri Kuldip Singh Suhag, as an Independent Director, not liable to retire by rotation, for a term of five consecutive years with effect from 1 December 2020, appointment of Shri Tilak Raj Bajalia, as an Independent Director, not liable to retire by rotation, for a term of five consecutive years with effect from 1 December 2020.Is New 90 Day High Low • Nov 25New 90-day low: ₹44.30The company is down 26% from its price of ₹60.10 on 27 August 2020. The Indian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period.Reported Earnings • Oct 21First half earnings releasedOver the last 12 months the company has reported total losses of ₹17.1m, with earnings decreasing by ₹354.7m from the prior year. Total revenue was ₹2.22b over the last 12 months, down 37% from the prior year.お知らせ • Oct 06Flowtech Industrial Projects Pvt. Ltd., Flow Tech Chemicals Private Limited, Sukhbir Singh Dahiya, Jagbir Singh Ahlawat, Jatin Dahiya and Parerna Ahlawat completed the acquisition of additional 34% stake in Punjab Alkalies & Chemicals Limited (BSE:506852) from Punjab State Industrial Development Corporation Ltd. and other public shareholders.Flowtech Industrial Projects Pvt. Ltd., Flow Tech Chemicals Private Limited, Sukhbir Singh Dahiya, Jagbir Singh Ahlawat, Jatin Dahiya and Parerna Ahlawat made an offer to acquire additional 26% stake in Punjab Alkalies & Chemicals Limited (BSE:506852) from Punjab State Industrial Development Corporation Ltd. and other public shareholders for approximately INR 280 million on August 5, 2020. Under the terms, the size of this offer is 7.05 million fully paid up equity shares representing 26% of the total outstanding share capital of Punjab Alkalies & Chemicals and the offer per share is INR 39.1 and it will be payable in cash. As on September 14, 2020, the terms were revised and Flowtech Industrial Projects Pvt. Ltd., Flow Tech Chemicals Private Limited, Sukhbir Singh Dahiya, Jagbir Singh Ahlawat, Jatin Dahiya and Parerna Ahlawat will acquire additional 34% stake in Punjab Alkalies & Chemicals Limited (BSE:506852) from Punjab State Industrial Development Corporation Ltd. and other public shareholders for approximately INR 414 million. Under the terms the offer price was revised to INR 45 from INR 39.1 per equity share and the size of offer was revised to 9.2 million shares from 7.05 million shares. In a related transaction, Flowtech Industrial Projects Pvt. Ltd., Flow Tech Chemicals Private Limited, Sukhbir Singh Dahiya, Jagbir Singh Ahlawat, Jatin Dahiya and Parerna Ahlawat acquired 24.39% stake in Punjab Alkalies & Chemicals. The acquisition will be financed through internal accruals. The Offer is not a conditional to minimum level of acceptances and no statutory or other approvals required to complete the Offer. As of September 14, 2020, the Committee of Independent Directors of Punjab Alkalies recommended the open offer. The Tendering Period of the Offer shall commence on September 17, 2020 and close on September 30, 2020. NitiN Somani and Anchal Lohia of Sundae Capital Advisors Private Limited acted as financial advisor to the acquirers in this transaction. S P Gupta of Beetal Financial & Computer Services Private Limited acted registrar for Flow Tech Group of Industries and Flowtech Industrial Projects Private Limited. Corporate Professionals Capital Private Limited acted as financial advisor for Committee of Independent Directors. Flowtech Industrial Projects Pvt. Ltd., Flow Tech Chemicals Private Limited, Sukhbir Singh Dahiya, Jagbir Singh Ahlawat, Jatin Dahiya and Parerna Ahlawat completed the acquisition of additional 34% stake in Punjab Alkalies & Chemicals Limited (BSE:506852) from Punjab State Industrial Development Corporation Ltd. and other public shareholders on September 29, 2020. The settlement for the said open offer is schedule on or before October 15, 2020. As of October 5, 2020, the revised settlement date is October 8, 2020.お知らせ • Sep 12Punjab Alkalies & Chemicals Limited to Report Q1, 2021 Results on Aug 14, 2020Punjab Alkalies & Chemicals Limited announced that they will report Q1, 2021 results on Aug 14, 2020株主還元506852IN ChemicalsIN 市場7D14.1%1.1%2.0%1Y-8.7%-2.0%3.6%株主還元を見る業界別リターン: 506852過去 1 年間で-2 % の収益を上げたIndian Chemicals業界を下回りました。リターン対市場: 506852は、過去 1 年間で3.6 % のリターンを上げたIndian市場を下回りました。価格変動Is 506852's price volatile compared to industry and market?506852 volatility506852 Average Weekly Movement8.8%Chemicals Industry Average Movement6.0%Market Average Movement6.0%10% most volatile stocks in IN Market9.1%10% least volatile stocks in IN Market3.7%安定した株価: 506852の株価は、 Indian市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 506852の weekly volatility ( 9% ) は過去 1 年間安定していますが、依然としてIndianの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1975365Naveen Chopraprimochemicals.inプリモ・ケミカルズ社はインドで化学品の製造・販売を行っている。同社は、製紙・紙パルプ、石鹸・洗剤、直鎖アルキルベンゼン、ビスコース・レーヨン、水の脱塩、繊維・染料、アルミニウム産業向けの苛性ソーダ灰汁、水処理プラント、製紙、安定漂白粉、CPW・PVC、クロロメタン、その他の有機塩素化学品用途に使用される液体塩素を提供している。また、発電所や肥料工場の水の脱塩、金属の酸洗、各種金属塩化物の調製などに使用される塩酸、繊維の漂白、洗濯業、飲料水の消毒などに使用される次亜塩素酸ナトリウム、発電所の燃料や冷却剤、植物油の水素化、光ファイバーユニットなどに使用される水素ガスも提供している。旧社名はPunjab Alkalies & Chemicals Limitedで、2022年12月にPrimo Chemicals Limitedに社名変更した。プリモ・ケミカルズは1975年に設立され、本社はインドのチャンディーガルにある。もっと見るPrimo Chemicals Limited 基礎のまとめPrimo Chemicals の収益と売上を時価総額と比較するとどうか。506852 基礎統計学時価総額₹6.10b収益（TTM）₹153.71m売上高(TTM)₹5.62b39.7xPER（株価収益率1.1xP/Sレシオ506852 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計506852 損益計算書（TTM）収益₹5.62b売上原価₹3.57b売上総利益₹2.04bその他の費用₹1.89b収益₹153.71m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）0.63グロス・マージン36.38%純利益率2.74%有利子負債／自己資本比率32.2%506852 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/31 05:30終値2026/07/31 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Primo Chemicals Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Valuation Update With 7 Day Price Move • Jun 08Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹26.36, the stock trades at a trailing P/E ratio of 41.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 58% over the past three years.
New Risk • Jun 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 26% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.6% average weekly change). Market cap is less than US$100m (₹6.39b market cap, or US$67.2m).
Reported Earnings • May 06Full year 2026 earnings released: EPS: ₹0.63 (vs ₹0.15 in FY 2025)Full year 2026 results: EPS: ₹0.63 (up from ₹0.15 in FY 2025). Revenue: ₹5.81b (up 4.7% from FY 2025). Net income: ₹153.7m (up 332% from FY 2025). Profit margin: 2.6% (up from 0.6% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 42 percentage points per year, which is a significant difference in performance.
お知らせ • Apr 29Primo Chemicals Limited to Report Q4, 2026 Results on May 05, 2026Primo Chemicals Limited announced that they will report Q4, 2026 results on May 05, 2026
Valuation Update With 7 Day Price Move • Apr 02Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₹21.54, the stock trades at a trailing P/E ratio of 58.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 72% over the past three years.
New Risk • Feb 14New major risk - Revenue and earnings growthEarnings have declined by 20% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₹5.35b market cap, or US$59.0m).
Valuation Update With 7 Day Price Move • Jun 08Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹26.36, the stock trades at a trailing P/E ratio of 41.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 58% over the past three years.
New Risk • Jun 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 26% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.6% average weekly change). Market cap is less than US$100m (₹6.39b market cap, or US$67.2m).
Reported Earnings • May 06Full year 2026 earnings released: EPS: ₹0.63 (vs ₹0.15 in FY 2025)Full year 2026 results: EPS: ₹0.63 (up from ₹0.15 in FY 2025). Revenue: ₹5.81b (up 4.7% from FY 2025). Net income: ₹153.7m (up 332% from FY 2025). Profit margin: 2.6% (up from 0.6% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 42 percentage points per year, which is a significant difference in performance.
お知らせ • Apr 29Primo Chemicals Limited to Report Q4, 2026 Results on May 05, 2026Primo Chemicals Limited announced that they will report Q4, 2026 results on May 05, 2026
Valuation Update With 7 Day Price Move • Apr 02Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₹21.54, the stock trades at a trailing P/E ratio of 58.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 72% over the past three years.
New Risk • Feb 14New major risk - Revenue and earnings growthEarnings have declined by 20% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₹5.35b market cap, or US$59.0m).
Reported Earnings • Feb 14Third quarter 2026 earnings released: EPS: ₹0.04 (vs ₹0.09 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.04 (down from ₹0.09 in 3Q 2025). Revenue: ₹1.45b (flat on 3Q 2025). Net income: ₹10.5m (down 54% from 3Q 2025). Profit margin: 0.7% (down from 1.6% in 3Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 02Primo Chemicals Limited to Report Q3, 2026 Results on Feb 12, 2026Primo Chemicals Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 12, 2026
Reported Earnings • Nov 16Second quarter 2026 earnings released: EPS: ₹0.17 (vs ₹0.53 in 2Q 2025)Second quarter 2026 results: EPS: ₹0.17 (down from ₹0.53 in 2Q 2025). Revenue: ₹1.39b (up 3.6% from 2Q 2025). Net income: ₹41.6m (down 68% from 2Q 2025). Profit margin: 3.0% (down from 9.6% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance.
お知らせ • Nov 03Primo Chemicals Limited to Report Q2, 2026 Results on Nov 14, 2025Primo Chemicals Limited announced that they will report Q2, 2026 results at 12:15 PM, Indian Standard Time on Nov 14, 2025
お知らせ • Aug 18Primo Chemicals Limited, Annual General Meeting, Sep 30, 2025Primo Chemicals Limited, Annual General Meeting, Sep 30, 2025, at 14:00 Indian Standard Time.
Reported Earnings • Aug 16First quarter 2026 earnings released: EPS: ₹0.17 (vs ₹0.46 loss in 1Q 2025)First quarter 2026 results: EPS: ₹0.17 (up from ₹0.46 loss in 1Q 2025). Revenue: ₹1.42b (up 16% from 1Q 2025). Net income: ₹40.8m (up ₹153.3m from 1Q 2025). Profit margin: 2.9% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 65 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 04Primo Chemicals Limited to Report Q1, 2026 Results on Aug 14, 2025Primo Chemicals Limited announced that they will report Q1, 2026 results on Aug 14, 2025
Reported Earnings • Jun 04Full year 2025 earnings released: EPS: ₹0.15 (vs ₹1.05 loss in FY 2024)Full year 2025 results: EPS: ₹0.15 (up from ₹1.05 loss in FY 2024). Revenue: ₹5.76b (up 45% from FY 2024). Net income: ₹35.6m (up ₹288.9m from FY 2024). Profit margin: 0.6% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 53 percentage points per year, which is a significant difference in performance.
お知らせ • May 19Primo Chemicals Limited to Report Q4, 2025 Results on May 30, 2025Primo Chemicals Limited announced that they will report Q4, 2025 results on May 30, 2025
New Risk • Apr 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (0.7x net interest cover). Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₹7.00b market cap, or US$81.9m).
Valuation Update With 7 Day Price Move • Apr 03Investor sentiment improves as stock rises 36%After last week's 36% share price gain to ₹28.87, the stock trades at a trailing P/E ratio of 63.2x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 67% over the past three years.
Reported Earnings • Feb 18Third quarter 2025 earnings released: EPS: ₹0.09 (vs ₹0.63 loss in 3Q 2024)Third quarter 2025 results: EPS: ₹0.09 (up from ₹0.63 loss in 3Q 2024). Revenue: ₹1.49b (up 63% from 3Q 2024). Net income: ₹22.9m (up ₹174.8m from 3Q 2024). Profit margin: 1.5% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 39 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 01Primo Chemicals Limited to Report Q3, 2025 Results on Feb 14, 2025Primo Chemicals Limited announced that they will report Q3, 2025 results on Feb 14, 2025
New Risk • Jan 13New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.61b (US$99.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (0.05x net interest cover). Minor Risk Market cap is less than US$100m (₹8.61b market cap, or US$99.3m).
Recent Insider Transactions • Nov 23Insider recently sold ₹948k worth of stockOn the 19th of November, - Neelam sold around 25k shares on-market at roughly ₹38.55 per share. This transaction amounted to 9.1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹1.3m more than they bought in the last 12 months.
お知らせ • Nov 02Primo Chemicals Limited to Report Q2, 2025 Results on Nov 12, 2024Primo Chemicals Limited announced that they will report Q2, 2025 results on Nov 12, 2024
Reported Earnings • Aug 13First quarter 2025 earnings released: ₹0.46 loss per share (vs ₹0.18 loss in 1Q 2024)First quarter 2025 results: ₹0.46 loss per share (further deteriorated from ₹0.18 loss in 1Q 2024). Revenue: ₹1.28b (up 16% from 1Q 2024). Net loss: ₹112.5m (loss widened 162% from 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.
お知らせ • Aug 12Primo Chemicals Limited, Annual General Meeting, Sep 27, 2024Primo Chemicals Limited, Annual General Meeting, Sep 27, 2024, at 12:30 Indian Standard Time.
お知らせ • Aug 01Primo Chemicals Limited to Report Q1, 2025 Results on Aug 12, 2024Primo Chemicals Limited announced that they will report Q1, 2025 results on Aug 12, 2024
Reported Earnings • Jun 04Full year 2024 earnings released: ₹1.05 loss per share (vs ₹5.67 profit in FY 2023)Full year 2024 results: ₹1.05 loss per share (down from ₹5.67 profit in FY 2023). Revenue: ₹4.16b (down 41% from FY 2023). Net loss: ₹253.3m (down 118% from profit in FY 2023). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jun 01Primo Chemicals Limited Announces Chief Financial Officer Changes, Effective from July 1, 2024Primo Chemicals Limited at the board meeting held on May 30, 2024, approved the appointment of CA Sunil Parsad as Chief Financial Officer (KMP) of the Company in place of Shri Arun Kumar Kaushal with effect from July 1, 2024. CA Sunil Parsad is B.com, M.com and a qualified Chartered Accountant. He is having a vast experience of around 20+ years in Fund Raising, Finalization of Balance Sheets, Accounts & Finance Control Functions, Arrangement & Management of working capital & Project Finance, Income Tax, TDS, GST, Companies Act, SAP Implementation, managing Statutory & Internal Audit, FEMA/RBI Compliances for export /import & ODI, etc. He has also gained certifications in IND AS Professional from Ernst & Young Associates LLP and Fraud Detection and Forensic Examinations from West Virginia University.
お知らせ • May 16Primo Chemicals Limited to Report Q4, 2024 Results on May 30, 2024Primo Chemicals Limited announced that they will report Q4, 2024 results on May 30, 2024
New Risk • May 06New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company.
New Risk • Apr 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
New Risk • Mar 28New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.26b (US$99.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company.
Reported Earnings • Feb 11Third quarter 2024 earnings released: ₹0.63 loss per share (vs ₹1.24 profit in 3Q 2023)Third quarter 2024 results: ₹0.63 loss per share (down from ₹1.24 profit in 3Q 2023). Revenue: ₹951.3m (down 49% from 3Q 2023). Net loss: ₹151.9m (down 151% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 56% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Nov 05Second quarter 2024 earnings released: ₹0.53 loss per share (vs ₹1.72 profit in 2Q 2023)Second quarter 2024 results: ₹0.53 loss per share (down from ₹1.72 profit in 2Q 2023). Revenue: ₹932.0m (down 50% from 2Q 2023). Net loss: ₹129.4m (down 131% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has increased by 81% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Oct 28Primo Chemicals Limited to Report Q2, 2024 Results on Nov 04, 2023Primo Chemicals Limited announced that they will report Q2, 2024 results on Nov 04, 2023
Reported Earnings • Aug 17First quarter 2024 earnings released: ₹0.18 loss per share (vs ₹1.98 profit in 1Q 2023)First quarter 2024 results: ₹0.18 loss per share (down from ₹1.98 profit in 1Q 2023). Revenue: ₹1.10b (down 41% from 1Q 2023). Net loss: ₹42.9m (down 109% from profit in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 90% per year but the company’s share price has only increased by 84% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 15Primo Chemicals Limited, Annual General Meeting, Sep 29, 2023Primo Chemicals Limited, Annual General Meeting, Sep 29, 2023, at 12:30 Indian Standard Time.
お知らせ • Aug 04Primo Chemicals Limited to Report Q1, 2024 Results on Aug 14, 2023Primo Chemicals Limited announced that they will report Q1, 2024 results on Aug 14, 2023
Reported Earnings • May 30Full year 2023 earnings released: EPS: ₹5.67 (vs ₹2.50 in FY 2022)Full year 2023 results: EPS: ₹5.67 (up from ₹2.50 in FY 2022). Revenue: ₹7.34b (up 62% from FY 2022). Net income: ₹1.34b (up 136% from FY 2022). Profit margin: 18% (up from 13% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 106% per year but the company’s share price has increased by 112% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Mar 31Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹80.93, the stock trades at a trailing P/E ratio of 12.1x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 1,295% over the past three years.
Valuation Update With 7 Day Price Move • Feb 17Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹78.70, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 1,194% over the past three years.
Reported Earnings • Feb 12Third quarter 2023 earnings released: EPS: ₹1.24 (vs ₹1.77 in 3Q 2022)Third quarter 2023 results: EPS: ₹1.24 (down from ₹1.77 in 3Q 2022). Revenue: ₹1.92b (up 47% from 3Q 2022). Net income: ₹300.3m (down 30% from 3Q 2022). Profit margin: 16% (down from 33% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has increased by 119% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Feb 03Primo Chemicals Limited to Report Q3, 2023 Results on Feb 10, 2023Primo Chemicals Limited announced that they will report Q3, 2023 results on Feb 10, 2023
お知らせ • Jan 14Primo Chemicals Limited Announces Commissioning of Stable Bleaching Powder ((SBP) Plant At Naya Nangal, PunjabPrimo Chemicals Limited informed that the Company is commissioning Stable Bleaching Powder (SBP) Plant at Naya Nangal, Punjab, having capacity of 33000 MT Per Annum. Name of the Product: Stable Bleaching Powder. Date of launch: January 13, 2023. Category of the Product: Speciality Chemicals.
Board Change • Nov 16High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. No highly experienced directors. MD, Director of Marketing & Executive Director Naveen Chopra is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Oct 30Second quarter 2023 earnings released: EPS: ₹1.72 (vs ₹1.57 loss in 2Q 2022)Second quarter 2023 results: EPS: ₹1.72 (up from ₹1.57 loss in 2Q 2022). Revenue: ₹1.95b (up 124% from 2Q 2022). Net income: ₹417.7m (up ₹790.5m from 2Q 2022). Profit margin: 22% (up from net loss in 2Q 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has increased by 113% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Oct 20Punjab Alkalies & Chemicals Limited to Report Q2, 2023 Results on Oct 28, 2022Punjab Alkalies & Chemicals Limited announced that they will report Q2, 2023 results on Oct 28, 2022
お知らせ • Aug 12Punjab Alkalies & Chemicals Limited, Annual General Meeting, Sep 15, 2022Punjab Alkalies & Chemicals Limited, Annual General Meeting, Sep 15, 2022, at 12:30 Indian Standard Time.
Reported Earnings • Aug 02First quarter 2023 earnings released: EPS: ₹1.98 (vs ₹0.48 in 1Q 2022)First quarter 2023 results: EPS: ₹1.98 (up from ₹0.48 in 1Q 2022). Revenue: ₹1.91b (up 154% from 1Q 2022). Net income: ₹480.0m (up 439% from 1Q 2022). Profit margin: 25% (up from 12% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 94% per year, which means it is well ahead of earnings.
お知らせ • Jul 26Punjab Alkalies & Chemicals Limited to Report Q1, 2023 Results on Aug 01, 2022Punjab Alkalies & Chemicals Limited announced that they will report Q1, 2023 results on Aug 01, 2022
Valuation Update With 7 Day Price Move • Jun 23Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₹62.65, the stock trades at a trailing P/E ratio of 26.8x. Average trailing P/E is 16x in the Chemicals industry in India. Total returns to shareholders of 336% over the past three years.
Reported Earnings • May 20Full year 2022 earnings released: EPS: ₹13.07 (vs ₹0.59 in FY 2021)Full year 2022 results: EPS: ₹13.07 (up from ₹0.59 in FY 2021). Revenue: ₹4.69b (up 107% from FY 2021). Net income: ₹567.2m (up ₹484.8m from FY 2021). Profit margin: 12% (up from 3.6% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has increased by 75% per year, which means it is tracking significantly ahead of earnings growth.
Board Change • Apr 27High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. MD, Director of Marketing & Executive Director Naveen Chopra is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹1.77 (up from ₹0.26 in 3Q 2021). Revenue: ₹1.31b (up 125% from 3Q 2021). Net income: ₹429.5m (up ₹393.7m from 3Q 2021). Profit margin: 33% (up from 6.1% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 178 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 04Punjab Alkalies & Chemicals Limited to Report Q3, 2022 Results on Feb 11, 2022Punjab Alkalies & Chemicals Limited announced that they will report Q3, 2022 results on Feb 11, 2022
Recent Insider Transactions • Jan 07Independent Non-Executive Director recently bought ₹146k worth of stockOn the 31st of December, Kuldip Suhag bought around 500 shares on-market at roughly ₹292 per share. In the last 3 months, there was an even bigger purchase from another insider worth ₹1.7m. Insiders have collectively bought ₹6.8m more in shares than they have sold in the last 12 months.
Recent Insider Transactions • Nov 23Insider recently bought ₹1.0m worth of stockOn the 16th of November, Divya Suhag bought around 6k shares on-market at roughly ₹170 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought ₹2.0m more in shares than they have sold in the last 12 months.
Reported Earnings • Nov 13Second quarter 2022 earnings released: ₹7.87 loss per share (vs ₹1.28 profit in 2Q 2021)The company reported a poor second quarter result with weaker earnings, revenues and control over costs. Second quarter 2022 results: Revenue: ₹8.94m (down 98% from 2Q 2021). Net loss: ₹3.73m (down 111% from profit in 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 98 percentage points per year, which is a significant difference in performance.
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹133, the stock trades at a trailing P/E ratio of 31.4x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 89% over the past three years.
Executive Departure • Sep 06Additional Independent Director Sanjiv Agarwal has left the companyOn the 27th of August, Sanjiv Agarwal's tenure as Additional Independent Director ended after less than a year in the role. We don't have any record of a personal shareholding under Sanjiv's name. A total of 5 executives have left over the last 12 months.
Executive Departure • Aug 25Additional Independent Director Girish Bhagat has left the companyOn the 18th of August, Girish Bhagat's tenure as Additional Independent Director ended after less than a year in the role. We don't have any record of a personal shareholding under Girish's name. A total of 4 executives have left over the last 12 months.
Reported Earnings • Aug 15First quarter 2022 earnings released: EPS ₹2.41 (vs ₹1.23 loss in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹780.4m (up 114% from 1Q 2021). Net income: ₹89.0m (up ₹122.3m from 1Q 2021). Profit margin: 11% (up from net loss in 1Q 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Jul 26Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹111, the stock trades at a trailing P/E ratio of 37.3x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 93% over the past three years.
お知らせ • May 24Punjab Alkalies & Chemicals Limited announced that it has received INR 324 million in funding from Plutus Wealth Management LLP and other investorsOn May 22, 2021, Punjab Alkalies & Chemicals Limited (BSE:506852) closed the transaction. The transaction has been approved by the board of directors of the company.
Reported Earnings • May 24Full year 2021 earnings released: EPS ₹2.97 (vs ₹3.24 in FY 2020)The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2021 results: Revenue: ₹2.81b (down 3.1% from FY 2020). Net income: ₹82.4m (down 6.5% from FY 2020). Profit margin: 2.9% (in line with FY 2020). Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.
お知らせ • Mar 18Punjab Alkalies & Chemicals Limited announced that it expects to receive INR 324 million in funding from Plutus Wealth Management LLP, and other investorsPunjab Alkalies & Chemicals Limited (BSE:506852) announced a private placement of 5,400,000 shares at issue price of INR 60 per share for gross proceeds of INR 324,000,000 on March 16, 2021. The transaction will include participation from Plutus Wealth Management LLP for 2,500,000 shares, Hemlata Kamal Poddar for 400,000 shares, Arun Kumar Poddar for 400,000 shares, Anita Kedia, Anup Gupta, Nand Kishore Agarwal, Rajesh Gadodia, Rajesh Kumar Agarwal, Ratiraj Tibrewal, Shyamsunder Bharubaxn Mandawewala, Poonam Sunil Bagaria, Amar Jeet Singh Randhawa, Aman Preet Singh Sohi for 200,000 shares each, and Sameer Agarwal for 100,000 shares. The transaction has been approved by the board of directors of the company. The company will raise money through preferential allotment.
Is New 90 Day High Low • Mar 09New 90-day high: ₹61.70The company is up 26% from its price of ₹48.90 on 09 December 2020. The Indian market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.
Reported Earnings • Feb 13Third quarter 2021 earnings released: EPS ₹1.32 (vs ₹0.02 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹653.0m (up 10.0% from 3Q 2020). Net income: ₹35.8m (up ₹36.3m from 3Q 2020). Profit margin: 5.5% (up from net loss in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 34% per year, which means it is well ahead of earnings.
お知らせ • Feb 05Punjab Alkalies & Chemicals Limited to Report Q3, 2021 Results on Feb 12, 2021Punjab Alkalies & Chemicals Limited announced that they will report Q3, 2021 results on Feb 12, 2021
お知らせ • Feb 04Punjab Alkalies & Chemicals Limited Announces Board AppointmentsThe Board of Directors of Punjab Alkalies & Chemicals Limited in its meeting held on February 03, 2021 approved appointment of Shri Girish Bhagat as Additional Director in an Independent capacity with effect from February 03, 2021 and appointment of Dr. Sanjiv Agarwal as Additional Director in an Independent capacity with effect from February 3, 2021 till the date of the next Annual General Meeting.
Is New 90 Day High Low • Jan 20New 90-day high: ₹55.35The company is up 13% from its price of ₹49.00 on 22 October 2020. The Indian market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.
お知らせ • Dec 02Punjab Alkalies & Chemicals Limited Approves Directorate AppointmentPunjab Alkalies & Chemicals Limited at its EGM held on December 1, 2020 approved the appointment of Shri Ashok Goyal as an Independent Director, not liable to retire by rotation, for a term of five consecutive years with effect from 1 December 2020, appointment of Shri Kuldip Singh Suhag, as an Independent Director, not liable to retire by rotation, for a term of five consecutive years with effect from 1 December 2020, appointment of Shri Tilak Raj Bajalia, as an Independent Director, not liable to retire by rotation, for a term of five consecutive years with effect from 1 December 2020.
Is New 90 Day High Low • Nov 25New 90-day low: ₹44.30The company is down 26% from its price of ₹60.10 on 27 August 2020. The Indian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period.
Reported Earnings • Oct 21First half earnings releasedOver the last 12 months the company has reported total losses of ₹17.1m, with earnings decreasing by ₹354.7m from the prior year. Total revenue was ₹2.22b over the last 12 months, down 37% from the prior year.
お知らせ • Oct 06Flowtech Industrial Projects Pvt. Ltd., Flow Tech Chemicals Private Limited, Sukhbir Singh Dahiya, Jagbir Singh Ahlawat, Jatin Dahiya and Parerna Ahlawat completed the acquisition of additional 34% stake in Punjab Alkalies & Chemicals Limited (BSE:506852) from Punjab State Industrial Development Corporation Ltd. and other public shareholders.Flowtech Industrial Projects Pvt. Ltd., Flow Tech Chemicals Private Limited, Sukhbir Singh Dahiya, Jagbir Singh Ahlawat, Jatin Dahiya and Parerna Ahlawat made an offer to acquire additional 26% stake in Punjab Alkalies & Chemicals Limited (BSE:506852) from Punjab State Industrial Development Corporation Ltd. and other public shareholders for approximately INR 280 million on August 5, 2020. Under the terms, the size of this offer is 7.05 million fully paid up equity shares representing 26% of the total outstanding share capital of Punjab Alkalies & Chemicals and the offer per share is INR 39.1 and it will be payable in cash. As on September 14, 2020, the terms were revised and Flowtech Industrial Projects Pvt. Ltd., Flow Tech Chemicals Private Limited, Sukhbir Singh Dahiya, Jagbir Singh Ahlawat, Jatin Dahiya and Parerna Ahlawat will acquire additional 34% stake in Punjab Alkalies & Chemicals Limited (BSE:506852) from Punjab State Industrial Development Corporation Ltd. and other public shareholders for approximately INR 414 million. Under the terms the offer price was revised to INR 45 from INR 39.1 per equity share and the size of offer was revised to 9.2 million shares from 7.05 million shares. In a related transaction, Flowtech Industrial Projects Pvt. Ltd., Flow Tech Chemicals Private Limited, Sukhbir Singh Dahiya, Jagbir Singh Ahlawat, Jatin Dahiya and Parerna Ahlawat acquired 24.39% stake in Punjab Alkalies & Chemicals. The acquisition will be financed through internal accruals. The Offer is not a conditional to minimum level of acceptances and no statutory or other approvals required to complete the Offer. As of September 14, 2020, the Committee of Independent Directors of Punjab Alkalies recommended the open offer. The Tendering Period of the Offer shall commence on September 17, 2020 and close on September 30, 2020. NitiN Somani and Anchal Lohia of Sundae Capital Advisors Private Limited acted as financial advisor to the acquirers in this transaction. S P Gupta of Beetal Financial & Computer Services Private Limited acted registrar for Flow Tech Group of Industries and Flowtech Industrial Projects Private Limited. Corporate Professionals Capital Private Limited acted as financial advisor for Committee of Independent Directors. Flowtech Industrial Projects Pvt. Ltd., Flow Tech Chemicals Private Limited, Sukhbir Singh Dahiya, Jagbir Singh Ahlawat, Jatin Dahiya and Parerna Ahlawat completed the acquisition of additional 34% stake in Punjab Alkalies & Chemicals Limited (BSE:506852) from Punjab State Industrial Development Corporation Ltd. and other public shareholders on September 29, 2020. The settlement for the said open offer is schedule on or before October 15, 2020. As of October 5, 2020, the revised settlement date is October 8, 2020.
お知らせ • Sep 12Punjab Alkalies & Chemicals Limited to Report Q1, 2021 Results on Aug 14, 2020Punjab Alkalies & Chemicals Limited announced that they will report Q1, 2021 results on Aug 14, 2020
